[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:amyloid":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Amyloid",30,22,[8,16,22,29,35,42,48,55,61,67,73,78,84,90,96,102,108,114,120,126,132,138,145,152,159,165,171,177,183,189],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07011745","A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease",[12],"Phase 3","RECRUITING","2026-08-26T02:15:36.077529Z","2026-07-30T01:46:14.435459Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07011732","A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)",[12],"2026-08-26T02:15:13.282904Z","2026-07-05T05:32:16.732821Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT06651567","A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia",[26],"Phase 2","2026-08-26T02:15:01.639696Z","2026-05-05T02:43:28.704728Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07178210","Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease",[],"2026-08-26T02:15:20.225313Z","2026-05-05T02:43:28.190977Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT06775964","Stem Cell Therapy for Early Alzheimer's Disease",[39],"Phase 1\u002FPhase 2","2026-08-26T02:17:01.714035Z","2026-05-05T02:43:27.929167Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06189963","Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease",[39],"2026-08-26T02:16:51.982021Z","2026-05-05T02:43:27.132573Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":53,"content_modified":54},"NCT05606341","Innate Immunity Stimulation Via TLR9 in Early AD",[52],"Phase 1","2026-08-26T02:18:26.932189Z","2026-05-05T02:43:26.924517Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT07094516","A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease",[26],"2026-08-26T02:18:45.196599Z","2026-05-05T02:43:26.769742Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT06540833","A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease",[26],"2026-08-26T02:18:47.742071Z","2026-05-05T02:35:31.899679Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT06548191","TREAD: Time Restricted Eating Intervention for Alzheimer's Disease",[52],"2026-08-26T02:16:32.589113Z","2026-05-05T02:35:31.870391Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":53,"content_modified":77},"NCT06801639","Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms",[],"2026-05-05T02:35:31.624285Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT07169578","A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease",[12],"2026-08-26T02:18:36.226508Z","2026-05-05T02:43:29.054228Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT07170150","A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease",[12],"2026-08-26T02:18:57.189473Z","2026-04-29T02:57:57.175631Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT05776641","Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People At Risk for Alzheimer's Disease",[],"2026-08-26T02:17:52.450442Z","2026-05-05T02:43:27.338324Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT07636811","A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)",[26],"2026-08-26T02:15:53.461103Z","2026-06-14T18:39:22.255860Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT07127510","Brain NAD in Alzheimer's Disease",[],"2026-08-26T02:16:59.895916Z","2026-05-13T02:55:06.656963Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":112,"content_modified":113},"NCT05925621","Cognitive Neurology Unit Clinical Registry",[],"2026-08-26T02:19:00.742020Z","2026-05-13T02:55:06.397456Z",{"nct_id":115,"title":116,"phases":117,"status":13,"updated_at":118,"content_modified":119},"NCT06957418","Alzheimer's Tau Platform: Master Protocol",[26],"2026-08-26T02:16:01.910993Z","2026-07-19T19:36:05.141067Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":124,"content_modified":125},"NCT07701161","Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device",[],"2026-08-26T02:18:32.765187Z","2026-07-19T19:36:05.083304Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT05573490","Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study",[],"2026-08-26T02:17:21.315591Z","2026-05-05T02:43:27.999263Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":136,"content_modified":137},"NCT05984524","Gamma-Music Based Intervention for Mild Alzheimer's Disease",[],"2026-08-26T02:18:02.701182Z","2026-05-05T02:43:27.983873Z",{"nct_id":139,"title":140,"phases":141,"status":13,"updated_at":143,"content_modified":144},"NCT04740580","Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease",[142],"Early Phase 1","2026-08-26T02:17:15.156099Z","2026-05-05T02:35:31.748444Z",{"nct_id":146,"title":147,"phases":148,"status":149,"updated_at":150,"content_modified":151},"NCT06432166","2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients",[39],"NOT_YET_RECRUITING","2026-08-26T02:15:33.331531Z","2026-05-05T02:43:26.717323Z",{"nct_id":153,"title":154,"phases":155,"status":156,"updated_at":157,"content_modified":158},"NCT07167966","Alzheimer's Tau Platform: Regimen A - AADvac1",[26],"ENROLLING_BY_INVITATION","2026-08-26T02:18:06.247899Z","2026-07-19T19:36:05.136583Z",{"nct_id":160,"title":161,"phases":162,"status":156,"updated_at":163,"content_modified":164},"NCT06023446","Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?",[],"2026-08-26T02:17:43.321968Z","2026-06-16T05:54:08.094905Z",{"nct_id":166,"title":167,"phases":168,"status":156,"updated_at":169,"content_modified":170},"NCT05457998","BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers",[],"2026-08-26T02:18:31.944757Z","2026-06-16T05:54:08.033528Z",{"nct_id":172,"title":173,"phases":174,"status":156,"updated_at":175,"content_modified":176},"NCT06817902","TMS Pilot in Early AD II",[],"2026-08-26T02:17:58.890423Z","2026-06-16T05:54:07.781173Z",{"nct_id":178,"title":179,"phases":180,"status":156,"updated_at":181,"content_modified":182},"NCT05999084","Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry",[],"2026-08-26T02:17:25.718160Z","2026-05-13T02:55:06.400887Z",{"nct_id":184,"title":185,"phases":186,"status":156,"updated_at":187,"content_modified":188},"NCT06723015","Tau PET Outcomes With Anti-amyloid Immunotherapies",[26],"2026-08-26T02:18:37.277498Z","2026-06-16T05:54:07.768381Z",{"nct_id":190,"title":191,"phases":192,"status":193,"updated_at":194,"content_modified":195},"NCT04629495","Rapamycin - Effects on Alzheimer's and Cognitive Health",[26],"ACTIVE_NOT_RECRUITING","2026-08-03T03:09:02.952012Z","2026-05-05T02:43:28.515511Z"]